» Articles » PMID: 24562932

Combined Morphologic and Molecular Classification for Predicting Lymph Node Metastasis in Early-stage Colorectal Adenocarcinoma

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2014 Feb 25
PMID 24562932
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying reliable predictors of lymph node (LN) metastasis is clinically important, particularly for optimizing treatments for early colorectal cancer (ECC) patients. This study evaluated risk-predictive models of LN metastasis using several pathologic and molecular ECC parameters.

Methods: Tissue specimens from 179 patients with histologically confirmed ECC were enrolled. A total of 20 clinicopathological characteristics, including tumor budding, micropapillary structure, and mucinous differentiation, and 22 protein expressions related to cancer invasion in central and invasive front areas were evaluated for their predictive value for LN metastasis.

Results: Alongside conventional histopathological parameters, tumor budding and mucinous differentiation at the invasive front of ECCs and micropapillary structure were found to be independent predictive factors for LN metastasis. Immunohistochemical expressions of CXCL12 and p38-MAPK at the invasive front were also found to be associated with regional LN metastasis in ECC. Analytic logistic models, using combinations of statistically independent parameters, revealed their abilities to predict LN metastasis in ECC. Further, receiver operating characteristic analysis using combinations of 6 or 7 independent variables represented predictive performances (area under curve of 0.956 or 0.960, respectively) for LN metastasis in ECC.

Conclusions: The combined histomorphologic and molecular factors tested here might be able to predict for LN metastasis in ECC.

Citing Articles

Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.

Kim J, Rhee Y, Bae J, Kim J, Koh S, Lee H BMC Cancer. 2022; 22(1):861.

PMID: 35933369 PMC: 9357306. DOI: 10.1186/s12885-022-09957-8.


Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis.

Ichimasa K, Kudo S, Miyachi H, Kouyama Y, Ishida F, Baba T Mol Clin Oncol. 2017; 6(4):517-524.

PMID: 28413659 PMC: 5374909. DOI: 10.3892/mco.2017.1172.


CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.

Fang C, Fan C, Wang C, Huang Q, Meng W, Yu Y Oncotarget. 2016; 7(47):77389-77403.

PMID: 27764803 PMC: 5363593. DOI: 10.18632/oncotarget.12675.


Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Jung Y, Hyun C, Jin M, Park I, Chung Y, Shim B J Breast Cancer. 2016; 19(3):261-267.

PMID: 27721875 PMC: 5053310. DOI: 10.4048/jbc.2016.19.3.261.


Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Rogers A, Winter D, Heeney A, Gibbons D, Lugli A, Puppa G Br J Cancer. 2016; 115(7):831-40.

PMID: 27599041 PMC: 5046217. DOI: 10.1038/bjc.2016.274.